There are 594 resources available
377P - In silico exploration of furin-heparin interactions and GNPDA1 inhibitor development for glycosylation in NSCLC
Presenter: Rodrigo Ferreira
Session: Poster Display session
Resources:
Abstract
378P - LncRNA RP11-888D10.4 expression upregulates invasion and metastasis through epithelial-mesenchymal transition in lung cancer cells
Presenter: Jung-Jyh Hung
Session: Poster Display session
379P - Precursor T-cell Exhaustion Characterizes Improved Survival in Non-Immunotherapy Treated Oligometastatic Lung Adenocarcinoma with Brain Metastases
Presenter: Raphael Werner
Session: Poster Display session
380P - RRAS and RRAS2 hotspot mutations as novel actionable oncogenic drivers in lung adenocarcinoma
Presenter: Marc Ladanyi
Session: Poster Display session
381P - Empowering global oncology: DBS-TARGETenables high-sensitivity mutation detection anywhere
Presenter: liu jingjing
Session: Poster Display session
382P - Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma
Presenter: Cheng Zhan
Session: Poster Display session
383P - KRAS G12C vs. non-G12C non-small cell lung cancer (NSCLC): Insights from gene expression analysis
Presenter: Laura Pinto
Session: Poster Display session
384P - The role of LYCAT in EGFR-TKI resistance, NSCLC progression, and smoking-induced lung cancer
Presenter: Stephanie Lopez
Session: Poster Display session
Resources:
Abstract
385P - KRAS-dependent and independent impact of STK11 mutations in NSCLC: Clinical characteristics
Presenter: Nele Danielle Wagener
Session: Poster Display session
386P - Comparison between CSF circulating tumor DNA, cytology and imaging for diagnosis of leptomeningeal metastases in non-small cell lung cancer: A retrospective study
Presenter: Joyce Leung
Session: Poster Display session